55,99 €
This concise text presents best practices for all aspects of atrial fibrillation ablation as outlined in the new version of the VeniceChart International Consensus document, which is presented in conjunction with the biannual Venice Arrhythmias conference. In addition to discussing the latest in a-fib ablation research, this 2011 update covers all the key areas of therapy and patient management, including: * Techniques and technologies * Procedural endpoints * Patient management pre-, peri- and post-ablation * Prevention and treatment of complications * Definition of success and long-term results With contributions from the world's recognized thought leaders in this field, this book is a highly valuable source of information not only for specialists in electrophysiology, but also for general cardiologists, fellows in cardiology and others interested in this dynamic and increasingly important topic.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 355
Veröffentlichungsjahr: 2011
Contents
Cover
Title Page
Copyright
Advertisement
Preface
List of contributors
VeniceChart task force composition
VeniceChart Task Force Co-Chairmen
VeniceChart Task Force Working Groups
List of abbreviations
CHAPTER 1: Anatomy of structures relevant to atrial fibrillation ablation
Introduction
Left atrium
Pulmonary veins
Atrial septum/fossa ovalis
Superior vena cava
Left atrial appendage
Left atrial ridge and ligament of Marshall
Mitral isthmus
Interatrial conduction pathways alternative to Bachmann's bundle
Ganglionated plexi
Phrenic nerves
Esophagus
Conclusions
CHAPTER 2: Pathophysiology of atrial fibrillation
Introduction
Diseases associated with AF and the role of fibrosis
Genetic factors and ion channel diseases
Electrophysiological mechanisms
CHAPTER 3: Techniques and technologies for atrial fibrillation catheter ablation
PV isolation
Segmental/ostial PV isolation
Circumferential PV ablation
Circumferential/antral PVI
New tools and techniques to perform PV isolation
Electrogram-based ablation or CFAE ablation
Linear lesions
Autonomic GP ablation
Localization of left atrial GP by endocardial high-frequency stimulation
Catheter ablation of left atrial GP
Ablation of AF nests guided by real-time spectral mapping in sinus rhythm
Sequential ablation strategy
Future technologies
CHAPTER 4: Endpoints of catheter ablation for atrial fibrillation
PV isolation
Electrogram-based ablation or CFAEs ablation
Linear lesions
Autonomic GP ablation
Coronary sinus and other thoracic veins ablation
CHAPTER 5: Patient management pre-, during-, and postablation
Preablation management
Informed consent and preablation fasting
Management during ablation
Postprocedural management
Rhythm outcome
Antiarrhythmic therapy
Late surveillance
CHAPTER 6: Periprocedural and long-term anticoagulation
Introduction
Preablation anticoagulation and TEE
Anticoagulation during the ablation procedure
Postablation anticoagulation
CHAPTER 7: Periprocedural and late complications
Cardiac tamponade
Thromboembolic events
PV stenosis
PN injury
Atrioesophageal fistula
Periesophageal vagal injury
Vascular complications
Acute coronary artery injury
Air emboli
Catheter entrapment in the MV or PV
Organized left atrial tachyarrhythmias after AF ablation
Adverse impact on atrial contractility
Radiation exposure during catheter ablation of AF
CHAPTER 8: Short- and long-term efficacy of catheter ablation procedures for atrial fibrillation
Introduction
Definition of success
Acute efficacy of AF ablation
Mid- to long-term efficacy of AF ablation
Very long-term efficacy of AF ablation
Efficacy in nonparoxysmal AF
Mechanisms of AF ablation failure
Conclusion
CHAPTER 9: Indications to atrial fibrillation ablation and cost-effectiveness
Indications to catheter ablation of AF
Cost-effectiveness of catheter ablation
CHAPTER 10: Clinical trials on atrial fibrillation/ future perspectives
Catheter ablation compared with AADs as technique to maintain sinus rhythm
QoL, symptoms, and hospitalization
Meta-analyses of randomized trials comparing catheter ablation and AAD treatment
Effect on survival and TEs
Complications
Economic aspects
Perspectives onto measuring QoL in AF trials
Perspectives onto ongoing trials on catheter ablation of AF
Trials focused on mortality, hospitalizations, and stroke
Trials testing the effectiveness of catheter ablation early in the treatment of AF
Trials of AF ablation in patients with heart failure
Trials of AF ablation in patients with persistent and long-standing persistent AF
CHAPTER 11: Surgical approach/ablation
Historical aspects
Development of the CMP
Surgical ablation technology
Indications
Surgical techniques and outcomes
PVI, expanded lesion sets, hybrid
CHAPTER 12: Hospital equipment and facilities, personnel, training requirements, and competences
Hospital equipment, facilities, and technological requirements
Training and knowledge
Technical competence
Management of complications
Follow-up
Index
This edition first published 2011, © 2011 by John Wiley & Sons, Ltd.
Wiley-Blackwell is an imprint of John Wiley & Sons, formed by the merger of Wiley's global Scientific, Technical and Medical business with Blackwell Publishing.
Registered office: John Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial offices: 9600 Garsington Road, Oxford, OX4 2DQ, UK
The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
111 River Street, Hoboken, NJ 07030-5774, USA
For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell.
The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought.
The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by physicians for any particular patient. The publisher and the author make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of fitness for a particular purpose. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. Readers should consult with a specialist where appropriate. The fact that an organization or Website is referred to in this work as a citation and/or a potential source of further information does not mean that the author or the publisher endorses the information the organization or Website may provide or recommendations it may make. Further, readers should be aware that Internet Websites listed in this work may have changed or disappeared between when this work was written and when it is read. No warranty may be created or extended by any promotional statements for this work. Neither the publisher nor the author shall be liable for any damages arising herefrom.
Library of Congress Cataloging-in-Publication Data is available for this title
A catalogue record for this book is available from the British Library.
This book is published in the following electronic formats: ePDF 9781119963837; Wiley Online Library 9781119963868; ePub 9781119963844; Mobi 9781119963851
Preface
This book represents the extended version of the VeniceChart International Consensus Document on Atrial Fibrillation Ablation, 2011 Update, and includes the recent technological developments and progress on atrial fibrillation (AF) since our last edition. AF ablation has become a well-etablished, widespread treatment not only for patients with paroxysmal AF but also for patients with persistent and long-lasting persistent AF and is recognized by the most recent European and American guidelines on AF management.
As the list of contributors shows, many renowned experts have contributed to the preparation of the VeniceChart International Consensus Document and to the realization of this book. We are deeply indebted to all of them because without their enthusiasm and personal effort this volume would not have been possible. We also wish to acknowledge the unparalleled editorial work of Nick Godwin, Cathryn Gates, and Elisabeth Dodds of Wiley-Blackwell Publishers, as well as the invaluable dedication and assistance of Rita Reggiani, Raffaella Pieri, and Ludovica Fontana of Adria Congrex. Our heartfelt thanks go to our colleagues at the Texas Cardiac Arrhythmia Institute, in Austin, Texas, and at Ospedale Dell'Angelo, in Venice-Mestre, for the preparation and realization of both the VeniceChart International Consensus Document and the VeniceArrhythmias 2011 Workshop. In particular, we thank Drs Aldo Bonso, David J. Burkhardt, Andrea Corrado, Luigi Di Biase, Gianni Gasparini, Franco Giada, Michela Madalosso, Antonio Rossillo, Pasquale Santangeli, and Sakis Themistoclakis.
Last but not least, our gratitude goes to our families, without whose patience and continuous support we could not have accomplished this task. We are profoundly thankful to our wives, Carmen and Marina, our children, Francesca, Michele, Veronica, Eleonora, and grandchild Edoardo.
Andrea NataleAntonio Raviele
List of contributors
Pedro Adragao, MD Cardiology Department Hospital Santa Cruz Carnaxide, Portugal
Etienne Aliot, MD Cardio-vascular Diseases Department CHU de Brabois, Vandoeuvre-lès-Nancy, France
Maurits Allessie, MD Cardiovascular Research Institute Maastricht Maastricht, The Netherlands
Charles Antzelevitch, MD Masonic Medical Research Laboratory Utica, NY, USA
Thomas Arentz, MD Rhythmology Department Herz-Zentrum Bad Krozingen, Germany
Conor Barrett, MD Cardiac Arrhythmia Service Massachusetts General Hospital Boston, MA, USA
Cristina Basso, MD Cardiovascular Pathology Department University of Padua Medical School Padua, Italy
Stefano Benussi, MD Cardiac Surgery Department San Raffaele Hospital Milan, Italy
Antonio Berruezo, MD Cardiology Department Clinic Hospital Barcelona, Spain
Emanuele Bertaglia, MD Cardiology Department ULSS 13 Mirano Mirano, Italy
Carina Blomström-Lundqvist, MD Cardiology Department University Hospital in Uppsala Uppsala, Sweden
Aldo Bonso, MD Cardiovascular Department Dell'Angelo Hospital Venice-Mestre, Italy
Johannes Brachmann, MD Cardiology Department II Med Klinik Klinikum Coburg Coburg, Germany
Josep Brugada, MD Cardiology Department Thorax Institute, Clinic of Barcelona Barcelona, Spain
David J. Burkhardt, MD Texas Cardiac Arrhythmia Institute St. David's Medical Center Austin, TX, USA
José A. Cabrera, MD Arrhythmia Unit, Cardiology Department Quirón Hospital, Universidad Europea de Madrid Madrid, Spain
Hugh Calkins, MD Cardiology and Electrophysiology Department The Johns Hopkins Hospital Baltimore, MD, USA
David Callans, MD Cardiovascular Disease Department Hospital of the University of Pennsylvania Philadelphia, PA, USA
A. John Camm, MD Cardiac and Vascular Sciences St. George's Hospital Medical School London, UK
Riccardo Cappato, MD Electrophysiology Department Policlinico S. Donato San Donato Milanese, Italy
Shih-Ann Chen, MD Cardiology Department Veterans General Hospital Taipei, Taiwan
Stuart J. Connolly, MD Cardiology Department McMaster University Hamilton, ON, Canada
Andrea Corrado, MD Cardiology Department Dell'Angelo Hospital Venice-Mestre, Italy
Ralph Damiano Jr., MD Cardiothoracic Surgery Department Washington University in St. Louis-School of Medicine St. Louis, MO, USA
Roberto De Ponti, MD Cardiology Department Circolo Hospital and Macchi Foundation Varese, Italy
Paolo Della Bella, MD Cardiology Department San Raffaele Hospital Milan, Italy
Luigi Di Biase, MD Texas Cardiac Arrhythmia Institute St. David's Medical Center Austin, TX, USA
Paul Dorian, MD Cardiology Department St. Michael's Hospital Toronto, ON, Canada
James R. Edgerton, MD Cardiothoracic Surgery Department The Heart Hospital Dallas, TX, USA
Sabine Ernst, MD National Heart and Lung Institute Royal Brompton and Harefield Hospital Imperial CollegeLondon, UK
Jeronimo Farré, MD Cardiology Department Jiménez Díaz-Capio Foundation Madrid, Spain
Fiorenzo Gaita, MD Internal Medicine Department University of Turin Turin, Italy
Edward B. Gerstenfeld, MD Cardiac Electrophysiology Department University of California San Francisco, CA, USA
Michel Haïssaguerre, MD Cardiology Department Hôpital Haut-Lévêque, CHU de Bordeaux Bordeaux, France
Gerhard Hindricks, MD Herzzentrum Leitender Arzt Universität Leipzig Leipzig, Germany
Siew Y. Ho, MD Cardiac Morphology Department Royal Brompton Hospital Imperial College, London, UK
Mélèze Hocini, MD Cardiology Department Hôpital Haut-Lévêque, CHU de Bordeaux Bordeaux, France
Stefan H. Hohnloser, MD Electrophysiology Department J.W. Goethe University Frankfurt, Germany
Rodney P. Horton, MD Texas Cardiac Arrhythmia Institute St. David's Medical Center Austin, TX, USA
Yoshito Iesaka, MD Tsuchiura Kyodo Hospital Tsuchiura City, Japan
Warren M. Jackman, MD Heart Rhythm Institute Oklahoma City, OK, USA
Pierre Jaïs, MD Cardiology Department Hôpital Haut-Lévêque, CHU de Bordeaux Bordeaux, France
José Jalife, MD University of Michigan Ann Arbor, MI, USA
Luc J. Jordaens, MD Thoraxcenter, Clinical Electrophysiology Department Erasmus MC Rotterdam, The Netherlands
Jonathan M. Kalman, MD Cardiology Department Royal Melbourne and Western Hospitals Melbourne, Australia
Josef Kautzner, MD Cardiology Department Institute for Clinical and Experimental Medicine Prague, Czech Republic
David Keane, MD Cardiology Department St. Vincent's University Hospital Dublin, Ireland
Young-Hoon Kim, MD Cardiology and Electrophysiology Department Korea University Medical Center Seoul, South Korea
Paulus Kirchhof, MD School of Clinical & Experimental Medicine University of Birmingham Birmingham, UK
Hans Kottkamp, MD Herz-Zentrum Hirslanden Clinic Zürich, Switzerland
Karl H. Kuck, MD Cardiology Department Asklepios Klinik St. Georg Hamburg, Germany
Chu-Pak Lau, MD Cardiology Department University of Hong Kong-Queen Mary Hospital Hong Kong
Samuel Lévy, MD Cardiology Department CHU Hôpital Nord Marseille, France
Gregory Y.H. Lip, MD University Department of Medicine City HospitalBirmingham, UK
Jos G. Maessen, MD Cardiothoracic Surgery Department University of Maastricht Maastricht, The Netherlands
Helmut Mair, MD Cardiac Surgery Department University of Munich Munich, Germany
Domenico Mangino, MD Cardiovascular Department Dell'Angelo Hospital Venice-Mestre, Italy
Moussa Mansour, MD Cardiac Arrhythmia Department Massachusetts General Hospital Boston, MA, USA
Francis E. Marchlinski, MD Cardiovascular Division Hospital of the University of Pennsylvania Philadelphia, PA, USA
José L. Merino, MD Cardiology Department La Paz University Hospital Madrid, Spain
Gregory F. Michaud, MD Center for Advanced Management of Atrial Fibrillation Brigham and Women's Hospital Boston, MA, USA
Carlos A. Morillo, MD Arrhythmia & Pacing Department Hamilton General Hospital Hamilton, ON, Canada
Hiroshi Nakagawa, MD Heart Rhythm Institute University of Oklahoma Health Sciences Center Oklahoma City, OK, USA
Andrea Natale, MD Texas Cardiac Arrhythmia Institute St. David's Medical Center Austin, TX, USA
Hakan Oral, MD Cardiovascular Medicine Department University of MichiganAnn Arbor, MI, USA
Douglas L. Packer, MD Heart Rhythm Services Mayo Clinic Health Systems/St. Mary's Hospital Rochester, NY, USA
Carlo Pappone, MD Arrhythmology Department Villa Maria Cecilia Hospital Cotignola, Italy
Eric N. Prystowsky, MD Clinical Electrophysiology Laboratory St. Vincent Indianapolis Hospital Indianapolis, IN, USA
Antonio Raviele, MD Cardiovascular Department Arrhythmia Center & Center for Atrial Fibrillation Dell'Angelo Hospital Venice-Mestre, Italy
Vivek Y. Reddy, MD Cardiac Arrhythmia Department The Zena and Michael A. Wiener Cardiovascular Institute New York, NY, USA
Matthew Reynolds, MD Beth Israel Deaconess Medical Center Harvard Clinical Research Institute Boston, MA, USA
Antonio Rossillo, MD Cardiovascular Department Dell'Angelo Hospital Venice-Mestre, Italy
Eduardo Saad, MD Center for Atrial Fibrillation Pro-Cardiaco Hospital Rio de Janeiro, Brazil
Javier E. Sanchez, MD Texas Cardiac Arrhythmia Institute St. David's Medical Center Austin, TX, USA
Prashanthan Sanders, MD Centre for Heart Rhythm Disorders Royal Adelaide Hospital North Terrace, Adelaide, Australia
Pasquale Santangeli, MD Texas Cardiac Arrhythmia Institute St. David's Medical Center Austin, TX, USA
Vincenzo Santinelli, MD Arrhythmology Department Villa Maria Cecilia Hospital Cotignola, Italy
Mauricio Scanavacca, MD Heart Institute University of Sao Paulo Medical School Sao Paulo, Brazil
Martin J. Schalij, MD Cardiology Department Leiden Hospital Leiden, The Netherlands
Melvin M. Scheinman, MD Cardiac Electrophysiology Department University of California San Francisco, CA, USA
Richard J. Schilling, MD Cardiology Department St Bartholomew's Hospital London, UK
Robert A. Schweikert, MD Cardiology Department Akron General Medical Center Akron, OH, USA
Dipen Shah, MD Cardiology Cantonal Hospital of Geneva Geneva, Switzerland
Kalyanam Shivkumar, MD UCLA Cardiac Arrhythmia Center David Geffen School of Medicine at UCLA Los Angeles, CA, USA
Jasbir Sra, MD Aurora Cardiovascular Services Aurora Sinai Medical Center Milwaukee, WI, USA
Sakis Themistoclakis, MD Cardiovascular Department Dell'Angelo Hospital Mestre, Italy
Claudio Tondo, MD Arrhythmology Department Centro Cardiologico Monzino Milan, Italy
Isabelle C. van Gelder, MD Cardiology Department University Medical Center Groningen Groningen, The Netherlands
Panos E. Vardas, MD Cardiology Department Heraklion University Hospital Heraklion, Greece
Atul Verma, MD Cardiology Department Southlake Regional Health Center Toronto, ON, Canada
Albert L. Waldo, MD Harrington-McLaughlin Heart & Vascular Institute Division of Cardiovascular Medicine University Hospitals Case Medical Center Cleveland, OH, USA
David J. Wilber, MD Cardiology Department Loyola University Medical Center Chicago, IL, USA
Stephan Willems, MD Cardiology and Electrophysiology Department Herzzentrum Hamburg GmbH University Hamburg, Germany
Erik Wissner, MD Cardiology Department Asklepios Klinik St. Georg Hamburg, Germany
Francesca Zuffada, MD Arrhythmology Department Villa Maria Cecilia Hospital Cotignola, Italy
VeniceChart task force composition
VeniceChart Task Force Co-Chairmen
Andrea Natale, MD, FACC, FESC, FHRS
Antonio Raviele, MD, FESC, FHRS
VeniceChart Task Force Working Groups
Anatomy of structures relevant to atrial fibrillation ablation
Siew Y. Ho, MD—Working Group Chairman
Cristina Basso, MD
José A. Cabrera, MD
Andrea Corrado, MD
Jeronimo Farré, MD
Josef Kautzner, MD
Roberto De Ponti, MD—Working Group Liaison Member
Pathophysiology of atrial fibrillation
José Jalife, MD—Working Group Chairman
Maurits Allessie, MD
Charles Antzelevitch, MD
Yoshito Iesaka, MD
Warren M. Jackman, MD
Melvin M. Scheinman, MD
Shih-Ann Chen, MD—Working Group Liaison Member
Techniques and technologies for atrial fibrillation catheter ablation
Karl H. Kuck, MD—Working Group Chairman
Pedro Adragao, MD
David J. Burkhardt, MD
Pierre Jaïs, MD
David Keane, MD
Hiroshi Nakagawa, MD
Robert A. Schweikert, MD
Jasbir Sra, MD
Vivek K. Reddy, MD—Working Group Liaison Member
Endpoints of catheter ablation for atrial fibrillation
Michel Haïssaguerre, MD—Working Group Chairman
Conor Barrett, MD
Luigi Di Biase, MD
Sabine Ernst, MD
Fiorenzo Gaita, MD
Javier E. Sanchez, MD
Prashanthan Sanders, MD
Richard J. Schilling, MD
Stephan Willems, MD—Working Group Liaison Member
Patient management pre-, during-, and postablation
David J. Wilber, MD—Working Group Chairman
Etienne Aliot, MD
Edward B. Gerstenfeld, MD
Chu-Pak Lau, MD
Martin J. Schalij, MD
Dipen Shah, MD
Hans Kottkamp, MD—Working Group Liaison Member
Periprocedural and long-term anticoagulation
Stuart J. Connolly, MD—Working Group Chairman
David Callans, MD
Mélèze Hocini, MD
Gregory Y.H. Lip, MD
Gregory F. Michaud, MD
Albert L. Waldo, MD
Sakis Themistoclakis, MD—Working Group Liaison Member
Periprocedural and late complications
Francis E. Marchlinski, MD—Working Group Chairman
Thomas Arentz, MD
Rodney P. Horton, MD
Hakan Oral, MD
Antonio Rossillo, MD
Eduardo Saad, MD
Mauricio Scanavacca, MD
Riccardo Cappato, MD—Working Group Liaison Member
Short- and long-term efficacy of catheter ablation procedures for atrial fibrillation
Hugh Calkins, MD—Working Group Chairman
Emanuele Bertaglia, MD
Antonio Berruezo, MD
Aldo Bonso, MD
Jonathan M. Kalman, MD
Moussa Mansour, MD
Atul Verma, MD—Working Group Liaison Member
Indications to atrial fibrillation ablation and cost-effectiveness
Eric N. Prystowsky, MD—Working Group Chairman
Josep Brugada, MD
Samuel Lévy, MD
Matthew Reynolds, MD
Vincenzo Santinelli, MD
Panos E. Vardas, MD
Francesca Zuffada, MD
Carlo Pappone, MD—Working Group Liaison Member
Clinical trials on atrial fibrillation/future perspectives
A. John Camm, MD—Working Group Chairman
Carina Blomström-Lundqvist, MD
Paul Dorian, MD
Stefan H. Hohnloser, MD
Carlos A. Morillo, MD
Pasquale Santangeli, MD
Isabelle C. van Gelder, MD
Erik Wissner, MD
Paulus Kirchhof, MD—Working Group Liaison Member
Surgical approach/ablation
Ralph Damiano Jr.—Working Group Chairman
Stefano Benussi, MD
Young-Hoon Kim, MD
Jos G. Maessen, MD
Helmut Mair, MD
Domenico Mangino, MD
Kalyanam Shivkumar, MD
James R. Edgerton—Working Group Liaison Member
Hospital equipment and facilities, personnel, training requirements, and competences
Douglas L. Packer, MD—Working Group Chairman
Johannes Brachmann, MD
Paolo Della Bella, MD
Luc J. Jordaens, MD
José L. Merino, MD
Claudio Tondo, MD
Gerhard Hindricks, MD—Working Group Liaison Member
List of abbreviations
2D two-dimensional 3D three-dimensional 7-d HM 7-day Holter monitoring AA antiarrhythmic AADs antiarrhythmic drugs AATACAblation versus Amiodarone for Treatment of Afib in patients with CHF ACC American College of Cardiology ACGME American Accreditation Council of Graduate Medical Education ACT activated clotting time ADVICEAD enosine following pulmonary Vein Isolation to target dormant Conduction Elimination AF atrial fibrillation AF-CHF atrial fibrillation and congestive heart failure AFL atrial flutter AFNETAtrial Fibrillation competence NETwork AFSS atrial fibrillation severity scale AHA American Heart Association AMICAAtrial fibrillation Management In Congestive heart failure with Ablation APAFAblation for Paroxysmal Atrial Fibrillation APD action potential duration ARC-HFAblation versus medical Rate Control for atrial fibrillation in patients with Heart Failure AVN AV node AVRT/AVNRT atrioventricular reciprocating tachycardia/atrioventricular nodal reciprocating tachycardia CABANACatheter ABlation versus ANtiarrhythmic drug therapy for Atrial Fibrillation CABG coronary artery bypass grafting CACAFCatheter Ablation for the Cure of Atrial Fibrillation CAF chronic atrial fibrillation CECC conventional extra-corporeal circulation CFAE complex fractionated atrial electrogram CFE complex fractionated electrograms CHADSCongestive heart failure Hypertension Age Diabetes Stroke CHF congestive heart failure CMC circular mapping catheter CMP Cox-maze procedure CO cross over CPVA circumferential pulmonary vein ablation CS coronary sinus CT computed tomography CTE crista terminalis CV cardiovascular DC direct current DFs dominant frequencies EAM electroanatomic mapping EASTEarly treatment of Atrial fibrillation for Stroke prevention Trial ECG electrocardiography ECM extracellular matrix EGMs electrograms EHRA European Heart Rhythm Association ELR external loop recorder ESC European Society of Cardiology FAPs fractionated atrial potentials FFT fast Fourier transform GCV great cardiac vein GNs ganglions GP ganglionated plexi GWAS genome-wide association studies HCM hypertrophic cardiomyopathy HFS high-frequency stimulation HiFU high-intensity frequency-focused ultrasound HRS high-rate stimulation IAS interatrial septum ICD/CRT-D implantable cardioverter defibrillator/cardiac resynchronization therapy + defibrillator ICE intracardiac echocardiography ICER incremental cost-effectiveness ratio ICS intercostal space ICV inferior caval vein INHS Italian National Health Service INR international normalized ratio ITT intention to treat LA left atrium LAA left atrial appendage LAEF LA ejection fraction LARFA left atrium radiofrequency ablation LAT/FL left atrial tachycardia/flutter LI left inferior LIPV left inferior pulmonary vein LMWH low molecular weight heparin LPA left pulmonary artery LS left superior LSPV left superior pulmonary vein LVEF left ventricular ejection fraction LVF left ventricular function MCOT mobile continuous outpatient telemetry MECC minimized extra-corporeal circulation MLWHF Minnesota living with heart failure MMPs matrix metalloproteinases MPO myeloperoxidase MR magnetic resonance MRI magnetic resonance imaging MV mitral valve NA not available NR not reported NSR normal sinus rhythm OAC oral anticoagulation OS orifice PAF paroxysmal atrial fibrillation PFO patent foramen ovale PLA posterior left atrium PM pacemaker PN phrenic nerve PVAI pulmonary vein antrum isolation PVI pulmonary vein isolation PVs pulmonary veins QALY quality-adjusted life year QoL quality of life RA right atrium RAA right atrial appendage RAAFTRadiofrequency Ablation versus Antiarrhythmic drugs for atrial Fibrillation Treatment RAS renin-angiotensin system RF radiofrequency RFA radiofrequency ablation RFCA radiofrequency catheter ablation RI right inferior RIPV right inferior pulmonary vein RPA right pulmonary artery RS right superior RSPV right superior pulmonary vein SAN sino-atrial node SARAStudy of Ablation versus antiaRrhythmic drugs in persistent Atrial fibrillation SHD structural heart disease SNS sympathetic nervous system SVC superior vena cava SVCI Superior vena cava isolation TCL tachycardia cycle length TEE transesophageal echocardiogram TEs thromboembolic events TGF transforming growth factor TIA transient ischemic attack TSP transseptal puncture TTE transthoracic echocardiography TTEM transtelephonic electrocardiographic monitoring VASc vascular disease age VPSI vasovagal pacemaker study XLL extra linear lesions in left atrium
